Literature DB >> 12430905

Thalassemia and abnormal hemoglobin.

Suthat Fucharoen1, Pranee Winichagoon.   

Abstract

Thalassemia and abnormal hemoglobins are common genetic disorders in Asia. Thalassemia is not only an important public health problem but also a socio-economic problem of many countries in the region. The approach to deal with the thalassemic problem is to prevent and control birth of new cases. This requires an accurate identification of the couple at high risk for thalassemia. However, the diagnosis of thalassemia carrier states need several tests which are not practical for screening the population at large. Recently we have used two simple laboratory tests to screen for potential thalassemia carriers and hemoglobin E individuals. There is also a new development in using the automatic HPLC to diagnose thalassemic diseases and the carriers. This system gives both qualitative and quantitative analysis of hemoglobin components in the same run with good precision and reproducibility. The system has been applied to study thalassemia and abnormal Hb in adult and cord blood. This system has enabled us to do both prenatal and postnatal diagnosis of thalassemia within the few minutes. However, none of these screening tests can accurately give specific diagnosis of the thalassemia genotype. Specific thalassemia mutation can be carried out by DNA analysis. Many DNA techniques have been used for point mutation detection and small deletion. For the last few years there is a development of DNA chip technology that has been applied for thalassemia mutation as well. Clinically, thalassemia is very heterogeneous in the manifestation. In spite of seemingly identical genotypes, severity of beta thalassemic patients can vary greatly. Heterogeneity in the clinical manifestation of beta thalassemic diseases may occur from the nature of beta globin gene mutation, alpha thalassemia gene interaction and difference in the amount of Hb F production which is partly associated with a specific beta globin haplotype. However, there is still some beta thalassemia cases that have a mild clinical symptom without those known genetic fators interaction suggesting that there are other additional factors responsible for the mildness of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430905     DOI: 10.1007/bf03165094

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  4 in total

Review 1.  Management of thalassemia major (Cooley's anemia).

Authors:  S Piomelli; T Loew
Journal:  Hematol Oncol Clin North Am       Date:  1991-06       Impact factor: 3.722

2.  Clinical manifestation of beta-thalassemia/hemoglobin E disease.

Authors:  S Fucharoen; P Ketvichit; P Pootrakul; N Siritanaratkul; A Piankijagum; P Wasi
Journal:  J Pediatr Hematol Oncol       Date:  2000 Nov-Dec       Impact factor: 1.289

Review 3.  Update on thalassemia.

Authors:  P J Giardina; M W Hilgartner
Journal:  Pediatr Rev       Date:  1992-02

Review 4.  Thalassemia major 1995: older patients, new therapies.

Authors:  D Rund; E Rachmilewitz
Journal:  Blood Rev       Date:  1995-03       Impact factor: 8.250

  4 in total
  16 in total

Review 1.  Strategic challenges in neurotherapeutic pharmaceutical development.

Authors:  Christopher C Gallen
Journal:  NeuroRx       Date:  2004-01

2.  Completing the map of human genetic variation.

Authors:  Evan E Eichler; Deborah A Nickerson; David Altshuler; Anne M Bowcock; Lisa D Brooks; Nigel P Carter; Deanna M Church; Adam Felsenfeld; Mark Guyer; Charles Lee; James R Lupski; James C Mullikin; Jonathan K Pritchard; Jonathan Sebat; Stephen T Sherry; Douglas Smith; David Valle; Robert H Waterston
Journal:  Nature       Date:  2007-05-10       Impact factor: 49.962

3.  Top-down proteomics and direct surface sampling of neonatal dried blood spots: diagnosis of unknown hemoglobin variants.

Authors:  Rebecca L Edwards; Paul Griffiths; Josephine Bunch; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2012-09-20       Impact factor: 3.109

4.  Molecular basis and hematological features of hemoglobin variants in Southern Thailand.

Authors:  Vannarat Saechan; Chawadee Nopparatana; Chamnong Nopparatana; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2010-09-14       Impact factor: 2.490

5.  A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.

Authors:  Cristina Zuccato; Laura Breda; Francesca Salvatori; Giulia Breveglieri; Sara Gardenghi; Nicoletta Bianchi; Eleonora Brognara; Ilaria Lampronti; Monica Borgatti; Stefano Rivella; Roberto Gambari
Journal:  Ann Hematol       Date:  2012-03-31       Impact factor: 3.673

6.  Coexistence of Malaria and Thalassemia in Malaria Endemic Areas of Thailand.

Authors:  Jiraporn Kuesap; W Chaijaroenkul; K Rungsihirunrat; K Pongjantharasatien; Kesara Na-Bangchang
Journal:  Korean J Parasitol       Date:  2015-06-30       Impact factor: 1.341

7.  Misleading HbA1c Measurement in Diabetic Patients with Hemoglobin Variants.

Authors:  Manthana Mitchai; Nattakarn Suwansaksri; Suphakdee Seanseeha; Jindamanee Saenboonsiri; Putthichai Kraitree; Jirasak Piyapromdee; Atit Silsirivanit
Journal:  Med Sci (Basel)       Date:  2021-06-07

8.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

9.  Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.

Authors:  Giulia Breveglieri; Irene Mancini; Nicoletta Bianchi; Ilaria Lampronti; Francesca Salvatori; Enrica Fabbri; Cristina Zuccato; Lucia C Cosenza; Giulia Montagner; Monica Borgatti; Fiorella Altruda; Sharmila Fagoonee; Gianni Carandina; Michele Rubini; Vincenzo Aiello; Laura Breda; Stefano Rivella; Roberto Gambari; Alessia Finotti
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

10.  A novel gap-PCR with high resolution melting analysis for the detection of α-thalassaemia Southeast Asian and Filipino β°-thalassaemia deletion.

Authors:  Siew Leng Kho; Kek Heng Chua; Elizabeth George; Jin Ai Mary Anne Tan
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.